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Four hundred and thirty pregnant women were recruited at approximately 22 weeks
gestation at prenatal clinics. Of these, 86 (20%) were diagnosed as depressed. The
women were seen again at approximately 32 weeks gestation and after delivery.
Chronicity of depression was evidenced by continuing high depression scores in
those women diagnosed as depressed. Comorbid problems were chronically high
anxiety, anger, sleep disturbance, and pain scores. Less optimal outcomes for the
depressed women included lower gestational age and lower birthweight of their
newborns.
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INTRODUCTION
Depression is particularly prevalent in women during pregnancy, affecting
anywhere from 10% to 25% (Burt & Stein, 2002; Marcus et al., 2003; Nonacs
& Cohen, 2002). In a study in New Zealand, 13% of a sample of pregnant
women scored greater than 12 (Carter et al., 2005). In a sample in the U.S.,
using a BDI score of 14 as the cutpoint, over half the sample was categorized
as having signiﬁcant depression symptoms (Mckeen et al., 2001).
Mothers exhibiting depression during pregnancy are more likely to deliver
prematurely (Orr et al., 2002). Maternal symptoms of depression are also
related to birthweight (both corrected and uncorrected for gestational age),
with neonates of depressed mothers being at greater risk for low birthweight
(<3,700 grams) and small-for-gestational-age (<10th percentile) (Field et al.,
2004; Hoffman & Hatch, 2000). A number of risk factors have been identiﬁed
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for low birthweight including prenatal stress, anxiety, and depression (see
Valero de Bernabe´ et al., 2004 for a review). Prenatal depression has also been
associated with elevated cortisol levels in both the mother and the newborn
(Lundy et al.,1999), which, in turn, has been associated with prematurity and
low birthweight (Field et al., 2004).
Most prenatal depression studies have been conducted at one time point
during pregnancy. An exception is a longitudinal assessment across pregnancy
that reported a steady decrease of depressive tendencies across two prenatal
assessments compared to a postnatal assessment (Hayes & Muller, 2004). The
women were less depressed postnatally than prenatally. The purpose of the
present study was to determine whether prenatal depression observed early in
pregnancy persists across pregnancy, and to assess the neonatal outcome for
women who were chronically depressed during pregnancy.
METHODS
Participants
Four-hundred thirty pregnant womenwere recruited at approximately 22 weeks
gestation (R = 20–24 weeks, M = 22 weeks), at prenatal clinics at a university
hospital. Following informed consent, they were then given a diagnostic
interview, the Structured Clinical Interview for DSM IV Disorders (SCID),
to determine whether they were depressed or non-depressed. Twenty percent
(n= 86) of thewomenwere diagnosed as having dysthymia ormajor depression
disorder. The sample was low to middle SES on average and was distributed
55% Hispanic, 23% African-American, and 22% non-Hispanic white. The
depressed and non-depressed groups differed on socioeconomic status (M =
3.7 for the nondepressed and 4.0 for the depressed, p < 0.01). None of the
women tested positive for substance use or smoking, and none of the women
were receiving treatment or medications for depression.
Procedure
After the diagnostic interview, the mothers were given a battery of self-report
measures for comorbid problems including anxiety, anger, daily hassles, sleep
disturbances, and pain. They also provided a urine sample to be assayed for
cortisol. These measures were repeated at the subsequent prenatal visit at
approximately 32 weeks gestation (R = 30–35 weeks) and at the postnatal visit
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at 2 days (R = 1–4 days). Neonatal birth measures were also recorded at that
time.
Self-Report Measures
Structured Clinical Interview for DSM-IV Disorders (SCID). All women
in the study were given the SCID (research version) to determine depression
and anxiety diagnoses and to screen out other disorders including bipolar
disorder, schizophrenia, and other psychotic disorders. The women were
diagnosed with Dysthymia or Major Depression on the SCID based on DSM
IV symptoms. The DSM IV deﬁnes Major Depression Disorder as ﬁve (or
more) of the following symptoms being present nearly everyday during the
same two-week period, at least one of the symptoms being depressed mood
or loss of interest/pleasure. The symptoms are: (1) depressed most of the day;
(2) markedly diminished interest or pleasure in all or almost all activities
most of the day; (3) signiﬁcant weight loss when not dieting, or weight
gain, or decrease or increase in appetite; (4) insomnia or hypersomnia; (5)
psychomotor agitation or retardation; (6) fatigue or loss of energy; (7) feelings
of worthlessness or excessive or inappropriate guilt; and (8) diminished ability
to think or concentrate, or indecisiveness. Dysthymic Disorder is deﬁned as
depressed mood for most of the day for more days than not for at least two
years. To be classiﬁed as Dysthymic, the criteria are the presence of two or
more of the following symptoms: (1) poor appetite or overeating; (2) insomnia
or hypersomnia; (3) low energy or fatigue; (4) low self-esteem; (5) poor
concentration or difﬁculty making decisions; and (6) feelings of hopelessness.
Both depression types (Major Depression and Dysthymia) and those diagnosed
with co-morbid anxiety disorder were eligible for the study. The SCID was
administered by research associates following training and with continuing
supervision by a clinical psychologist.
Center for Epidemiological Studies Depression Scale (CES-D) (Radloff,
1977). This 20-item scale was included to assess symptoms of depression.
The women are asked to report on their feelings during the preceding week.
The scale has adequate test/retest reliability (0.60 over several weeks), internal
consistency (0.80–0.90), and concurrent validity (Wells et al., 1987). A score
of 16 on the CES-D is considered the cutpoint for depression (Radloff, 1991).
State/Trait Anxiety Inventory (STAI) (Spielberger et al., 1970). This scale
was used to assess co-morbidity of anxiety and depression. The State/Trait
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Anxiety Inventory is comprised of 20 items and is summarized by a score
ranging from 20 to 90 and assesses how the person usually feels in terms
of severity (“not at all” to “very much so”). Characteristic items include “I
feel nervous” and “I feel calm.” Research has demonstrated that the STAI has
adequate concurrent validity and internal consistency (r = .83). The cutoff
score for high anxiety in the present studies has been 48.
State/Trait Anger Inventory (STAXI) (Spielberger et al., 1995). This
is a 10-item inventory that assesses general feelings of anger based on a
4-point Likert scale ranging from 1 (almost never) to 4 (almost always).
Typical questions include “I am quick tempered” and “I ﬂy off the handle.”
Psychometric properties have been established for the STAXI on diverse ethnic
groups. Reliability coefﬁcients have been reported between 0.97 (state) and
0.89 (trait).
Daily Hassles Scale (Field, 2003). This scale was developed to assess the
degree of hassle being experienced by expectant mothers. The 16 items on
this 4-point Likert scale include questions on people such as family members,
landlord, and friends creating hassles and the problem of ﬁnding resources as
creating hassles.
Urine Assays. Urines were collected at the same time of day (mid-morning)
to control for diurnal variation and they were, then, frozen and subsequently
sent to Saul Schanberg and Cynthia Kuhn at Duke University Medical
School, where they were assayed for cortisol. Cortisol was measured in urine
by radioimmunoassay using a speciﬁc antiserum from Radioassay Systems
Laboratories. The sensitivity of the assay is 0.025 ng/tube. The inter-assay and
intra-assay coefﬁcient of variation is less than 10% and 5%, respectively.
RESULTS
Group by repeatedmeasures analyses of variancewere conducted on each of the
variables followed by Bonferroni t-tests for interaction effects. As can be seen
in Table 1, the group of women who had been diagnosed as depressed differed
across pregnancy (at both prenatal visits) and postnatally on the self-report
measures as follows: (1) higher depression (CES-D) scores, (2) higher anxiety
(STAI) scores, and (3) higher anger (STAXI) scores. The depressed group also
reported a greater number of daily hassles at the ﬁrst prenatal visit. At the
two prenatal visits they were noted to have: (1) greater sleep disturbances and
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Table 1. Means for self-report measures and cortisol at prenatal visit 1 (M = 20
weeks gestation), prenatal visit 2 (M = 32 weeks gestation) and postnatal visit
(M = 2 days). Means for depressed group are in parentheses
Visits
Prenatal visit 1 Prenatal visit 2 Postnatal visit
Variables
Depression (CES-D) 11.34 12.04 9.94
(22.5) (19.7) (19.0)
Anxiety (STAI) 34.14 37.43 33.11
(42.9) (43.2) (36.9)
Anger (STAXI) 17.34 16.24 16.04
(20.5) (22.3) (21.0)
Daily hassles 20.84
(24.7)
Sleep disturbance 39.31 42.11
(46.9) (51.5)
Back pain 3.51 3.61
(4.7) (5.5)
Leg pain 2.91 3.21
(4.0) (4.8)
Cortisol 141.41 195.5
(173.7) (216.9)
Superscripts are for non-depressed/depressed group comparisons (1p < 0.05,
2p < 0.01, 3p < 0.005, 4p < 0.001).
(2) greater back and leg pain. At the ﬁrst prenatal visit, the depressed group
had higher cortisol levels than the non-depressed group, and at the second
prenatal visit, the groups no longer differed on cortisol levels. As can be seen in
Table 2, the depressed group had newborns with less optimal neonatal outcomes
including: (1) lower gestational age and (2) lower birthweight.
DISCUSSION
Chronic depression has been noted in other samples of pregnant women (Diego
et al., 2004), and has been reported to have negative effects on neonatal
outcomes including shorter gestation and lower birthweight (Field et al., 2004).
Most samples of prenatally depressed women have only been assessed at
one time point during pregnancy. In the current study, the chronicity was
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Table 2. Means for neonatal measures
Groups
Non-depressed Depressed
Measures
Gestational age 39.1 37.52
Birthweight 3332.3 3093.31
Superscripts are for non-depressed/depressed group
comparisons (1p < 0.05, 2p < 0.01).
demonstrated at three points in time including the second and third trimesters
of pregnancy and postnatally.
Also unique to this study was the assessment of comorbidity on multiple
self-report scales. The chronicity of other problems in this sample like anxiety,
anger, sleep disturbances, and pain highlight the complexity of prenatal stress.
The comorbidity of these problems confounds the question of what predicts to
the shorter gestation and lower birthweight outcomes. The lower socioeconomic
status of the depressed group may have contributed to at least the greater
number of daily hassles reported by the depressed women. The generally lower
socioeconomic status of the entire sample may have also contributed to the
relatively high incidence of chronic depression in this sample (20%).
The elevated cortisol in the depressed group likely also contributed to the
shorter gestation and lower birthweight of the newborns, as it has in other
samples the authors have followed (Field et al., 2004). In the Field et al. (2004)
study, elevated cortisol at 20 weeks gestation was the strongest predictor of
prematurity and low birthweight. In the current study, cortisol levels were no
longer higher in the depressed group at the second prenatal assessment, aswould
be expected inasmuch as cortisol levels are noted to increase signiﬁcantly across
all pregnancies. But the Field et al. (2004) results would suggest that elevated
cortisol at the earlier stage of pregnancy (around 20 weeks) would be sufﬁcient
to heighten the risk of prematurity and low birthweight. Whether depression
itself contributed to elevated cortisol is not clear given that the comorbid factors
such as anxiety and anger may have also been related to elevated cortisol.
Further research is needed to explore relationships between depression and
cortisol, and cortisol and prematurity. The relative contributions of each of these
comorbid problems to the less optimal neonatal outcomes, as in a regression
or in a path analysis model, would help identify those problems most needing
prenatal intervention.
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